Home » Topics » Regulatory » Patents

Patents
RSS

Charite-Universitaetsmedizin Berlin, Sapreme Technologies present new saponin derivatives

Jan. 19, 2022

Idorsia Pharmaceuticals discovers Kv7 potassium channel activators

Jan. 19, 2022

Universite de Franche-Comte presents compounds targeting histamine H3 receptors

Jan. 18, 2022

Purdue Research Foundation patents protein kinase inhibitors

Jan. 18, 2022

Viral replication inhibitors patented by Gilead

Jan. 17, 2022

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Jan. 17, 2022

Celgene presents new cereblon-binding PROTACs

Jan. 17, 2022

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

BioWorld MedTech Patent Highlights: Week 1

From Current Patent Gazette

Jan. 14, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....